2017
DOI: 10.18632/oncotarget.15198
|View full text |Cite
|
Sign up to set email alerts
|

Design, sythesis and evaluation of a series of 3- or 4-alkoxy substituted phenoxy derivatives as PPARs agonists

Abstract: Peroxisome proliferators-activated receptors (PPARα, γ and δ) are potentially effective targets for Type 2 diabetes mellitus therapy. The severe effects of known glitazones and the successfully approved agents (saroglitazar and lobeglitazone) motivated us to study novelly potent PPARs drugs with improved safety profile. In this work, we received 15 carboxylic acids based on the combination principle to integrate the polar head of bezafibrate with the hydrophobic tail of pioglitazone. Another 12 tetrazoles base… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 43 publications
0
2
0
Order By: Relevance
“…In future, benzylidene-2,4-thiazolidinedione derivatives will be utilized to improve the synthesis of new PTP-1Binhibitors. Zhang et al, (2017) has synthesized 2-thioxo-4-thiazolidinone derivatives. These derivatives were analyzed for antidiabetic activity with respect to peroxisome proliferator activated receptor gama (PPARγ) binding activity comparable with rosiglitazone.…”
Section: Chemistry Of Thiazolidinedionesmentioning
confidence: 99%
“…In future, benzylidene-2,4-thiazolidinedione derivatives will be utilized to improve the synthesis of new PTP-1Binhibitors. Zhang et al, (2017) has synthesized 2-thioxo-4-thiazolidinone derivatives. These derivatives were analyzed for antidiabetic activity with respect to peroxisome proliferator activated receptor gama (PPARγ) binding activity comparable with rosiglitazone.…”
Section: Chemistry Of Thiazolidinedionesmentioning
confidence: 99%
“…Pioglitazone belongs to the thiazolidinedione class of drugs and was deemed as an insulin sensitizer for the therapy of T2DM [ 4 ]. As a highly selective agonist for peroxisome proliferator-activated receptor γ (PPAR- γ ), pioglitazone regulates the transcription of several genes and proteins involved in glucose and lipid metabolism [ 5 ].…”
Section: Introductionmentioning
confidence: 99%